KalGene Phamaceuticals
Description
KalGene is a biotechnology company developing precision medicine therapeutics designed to slow the progression of Alzheimer’s disease with an antibody-based approach
More information
- KalGene Pharmaceuticals, Inc. announces a new peer-review publication demonstrating the efficacy of KG207 in clearing toxic oligomer species of amyloid beta in translational imaging studies
- Kalgene Pharmaceuticals Inc., an Alzheimer’s focused company using a next generation engineered drug candidate, has appointed new leadership.
Back to list
Newsletter
Stay up to date on the
latest adMare news
Vancouver Innovation Centre
2405 Wesbrook Mall, 4th Floor
Vancouver, British Columbia, Canada
V6T 1Z3
T. 604.827.1147
Montreal Innovation Centre
7171 Frederick-Banting
Montréal, Québec, Canada
H4S 1Z9
T. 514.375.3334
Toronto Office
MaRS Centre, West Tower
661 University Ave., Suite 405
Toronto, Ontario, Canada
M5G 1M1
